Multiple ways of targeting APOBEC3–virion infectivity factor interactions for anti-HIV-1 drug development
Author:
Funder
National Cancer Institute
National Institutes of Health
Publisher
Elsevier BV
Subject
Pharmacology,Toxicology
Reference125 articles.
1. Challenges in the development of an HIV-1 vaccine;Barouch;Nature,2008
2. Failure of the Merck HIV vaccine: an uncertain step forward;Robb;Lancet,2008
3. The efficacy of azidothymidine (AZT) in the treatment of patients with AIDS and AIDS-related complex. A double-blind, placebo-controlled trial;Fischl;N. Engl. J. Med.,1987
4. Prevalence of resistance to nevirapine in mothers and children after single-dose exposure to prevent vertical transmission of HIV-1: a meta-analysis;Arrive;Int. J. Epidemiol.,2007
5. Beyond efficacy: the impact of combination antiretroviral therapy on quality of life;Sax;AIDS Patient Care STDS,2005
Cited by 44 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Potent dual block to HIV-1 infection using lentiviral vectors expressing fusion inhibitor peptide mC46- and Vif-resistant APOBEC3G;Molecular Therapy - Nucleic Acids;2023-09
2. Mutagenic Activity of AID/APOBEC Deaminases in Antiviral Defense and Carcinogenesis;Molecular Biology;2022-01
3. Impact of Human Leukocyte Antigen-Associated Polymorphisms on Variability of HIV-1 Accessory and Regulatory Proteins;AIDS Research and Human Retroviruses;2021-12-01
4. Development of Lentiviral Vectors for HIV-1 Gene Therapy with Vif-Resistant APOBEC3G;Molecular Therapy - Nucleic Acids;2019-12
5. Novel host restriction factors implicated in HIV-1 replication;Journal of General Virology;2018-04-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3